Login / Signup

Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor-mutant non-small cell lung cancer: A prospective, multicenter, dose-modification study.

Yukari TsubataTakeshi MasudaKosuke HamaiMasaya TaniwakiAkari TaninoTakamasa HottaMegumi HamaguchiShunichi HamaguchiMasahiro YamasakiNobuhisa IshikawaKazunori FujitakaAkihisa SutaniTakeshi Isobe
Published in: Geriatrics & gerontology international (2021)
Many older patients with epidermal growth factor receptor-mutant non-small cell lung cancer might require treatment dose reduction. Further studies are required to develop individualized treatments for older patients with lung cancer. Geriatr Gerontol Int 2021; 21: 881-886.
Keyphrases
  • epidermal growth factor receptor
  • advanced non small cell lung cancer
  • tyrosine kinase
  • community dwelling
  • middle aged
  • physical activity
  • wild type
  • cross sectional
  • smoking cessation